Skip to main content

Advertisement

Log in

Dataset for the reporting of carcinoma of the bladder—cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Virchows Archiv Aims and scope Submit manuscript

Abstract

The International Collaboration on Cancer Reporting (ICCR) is a not for profit organisation whose goal is to produce standardised internationally agreed and evidence-based datasets for pathology reporting. With input from pathologists worldwide, the datasets are intended to be uniform and structured. They include all items necessary for an objective and accurate pathology report which enables clinicians to apply the best treatment for the patient. This dataset has had input from a multidisciplinary ICCR expert panel. The rationale for some items being required and others recommended is explained, based on the latest literature. The dataset incorporates data from the World Health Organization (WHO) 2016, and also from the latest (8th edition) TNM staging system of the American Joint Committee on Cancer (AJCC). Fifteen required elements and eight recommended items are described. This dataset provides all the details for a precise and valuable pathology report required for patient management and prognostication. This dataset is intended for worldwide use, and should facilitate the collection of standardised comparable data on bladder carcinoma at an international level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

All ICCR datasets are freely available for worldwide use at the following website: http://www.iccr-cancer.org/datasets.

References

  1. World Health Organization (2016) In: Moch H, Humphrey P, Ulbright T, Reuter R (eds) WHO classification of umours of the urinary system and male genital organs. IARC Press, Lyon, France

    Google Scholar 

  2. Soave A, John LM, Dahlem R, Minner S, Engel O, Schmidt S, Kluth LA, Fisch M, Rink M (2015) The impact of tumor diameter and tumor necrosis on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urology 86(1):92–98

    PubMed  Google Scholar 

  3. Donat SM, Genega EM, Herr HW, Reuter VE (2001) Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 165(4):1117–1120

    CAS  PubMed  Google Scholar 

  4. Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M, National Comprehensive Cancer Network (NCCN) (2013) Bladder cancer. J Natl Compr Cancer Netw 11(4):446–475

    CAS  Google Scholar 

  5. Alanee S, Alvarado-Cabrero I, Murugan P, Kumar R, Nepple KG, Paner GP, Patel MI, Raspollini MR, Lopez-Beltran A, Konety BR (2019) Update of the international consultation on urological diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol 37(1):107–114

    PubMed  Google Scholar 

  6. Warrick JI, Sjodahl G, Kaag M, Raman JD, Merrill S, Shuman L et al (2019) Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants. Eur Urol 75(1):18–22

    CAS  PubMed  Google Scholar 

  7. Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney J, Montironi R, Paner GP, al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, Cheng L, Cheville JC, Kristiansen G, Cote RJ, Delahunt B, Eble JN, Genega EM, Gulmann C, Hartmann A, Langner C, Lopez-Beltran A, Magi-Galluzzi C, Merce J, Netto GJ, Oliva E, Rao P, Ro JY, Srigley JR, Tickoo SK, Tsuzuki T, Umar SA, van der Kwast T, Young RH, Soloway MS (2015) Update for the practicing pathologist: the international consultation on urologic disease-European association of urology consultation on bladder cancer. Mod Pathol 28(5):612–630

    PubMed  Google Scholar 

  8. Zhou HH, Liu LY, Yu GH, Qu GM, Gong PY, Yu X, Yang P (2017) Analysis of clinicopathological features and prognostic factors in 39 cases of bladder neuroendocrine carcinoma. Anticancer Res 37(8):4529–4537

    CAS  PubMed  Google Scholar 

  9. Gopalan A, Sharp DS, Fine SW, Tickoo SK, Herr HW, Reuter VE, Olgac S (2009) Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 33(5):659–668

    PubMed  PubMed Central  Google Scholar 

  10. Amin MB, Smith SC, Eble JN, Rao P, Choi WW, Tamboli P et al (2014) Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 38(8):1033–1045

    PubMed  Google Scholar 

  11. Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE et al (2014) Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol 45(7):1473–1482

    CAS  PubMed  Google Scholar 

  12. Kosem M, Sengul E (2005) Clear cell adenocarcinoma of the urinary bladder. Scand J Urol Nephrol 39(1):89–92

    PubMed  Google Scholar 

  13. Lah K, Desai D, Hadway P, Perry-Keene J, Coughlin G (2013) Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of mullerian origin. Anticancer Res 33(2):615–617

    PubMed  Google Scholar 

  14. Sung MT, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Cheng L (2008) Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 14(7):1947–1955

    CAS  PubMed  Google Scholar 

  15. Alexiev BA, Tavora F (2013) Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems. Virchows Arch 462(2):193–201

    CAS  PubMed  Google Scholar 

  16. Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J (1998) Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol 29(12):1451–1456

    CAS  PubMed  Google Scholar 

  17. Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB (2011) Hepatocyte nuclear factor-1beta expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis. Hum Pathol 42(11):1613–1619

    CAS  PubMed  Google Scholar 

  18. Reis LO, Billis A, Ferreira FT, Ikari LY, Stellini RF, Ferreira U (2011) Female urethral carcinoma: evidences to origin from Skene's glands. Urol Oncol 29(2):218–223

    PubMed  Google Scholar 

  19. Royce TJ, Lin CC, Gray PJ, Shipley WU, Jemal A, Efstathiou JA (2018) Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: results from the National Cancer Data Base. Urol Oncol 36(2):78.e1–78.e12

    Google Scholar 

  20. Moschini M, D’Andrea D, Korn S, Irmak Y, Soria F, Comperat E et al (2017) Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol 14(11):651–668

    PubMed  Google Scholar 

  21. Davaro F, Schaefer J, May A, Raza J, Siddiqui S, Hamilton Z (2019) Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database. World J Urol 37(3):497–505

    PubMed  Google Scholar 

  22. Shah JB, McConkey DJ, Dinney CP (2011) New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Clin Cancer Res 17(9):2608–2612

    PubMed  Google Scholar 

  23. Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, van Kessel K, Fransen van de Putte E, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjödahl G, Kardos J, Hoadley KA, Lerner SP, McConkey D, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhöfer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden M, Black PC (2017) Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 72(4):544–554

    CAS  PubMed  Google Scholar 

  24. Grignon D, Brimo F, Comperat E, Delahunt B, Koch M, Lopez-Beltran A, et al. (2018) Urinary tract carcinoma, histopathology reporting guide, biopsy and transurethral resection specimen, 1st Edition. In: Reporting ICoC, editor. Sydney, Australia

  25. Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475

    CAS  Google Scholar 

  26. Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA et al (2014) Micropapillary bladder cancer: current treatment patterns and review of the literature. Urol Oncol 32(6):826–832

    PubMed  PubMed Central  Google Scholar 

  27. Hansel DE, Amin MB, Comperat E, Cote RJ, Knuchel R, Montironi R et al (2013) A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 63(2):321–332

    PubMed  Google Scholar 

  28. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M et al (2018) European Association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111–122

    PubMed  Google Scholar 

  29. Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R (2016) Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. BJU Int 117(4):604–610

    PubMed  Google Scholar 

  30. Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF (2015) Corrigendum to “characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort” [Eur Urol 2010;57:300-9]. Eur Urol 68(1):171

    PubMed  Google Scholar 

  31. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435–1448

    CAS  PubMed  Google Scholar 

  32. Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG (2005) Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 173(4):1163–1168

    PubMed  Google Scholar 

  33. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG (2000) Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88(7):1663–1670

    CAS  PubMed  Google Scholar 

  34. Comperat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D et al (2019) SIU-ICUD on bladder cancer: pathology. World J Urol 37(1):41–50

    PubMed  Google Scholar 

  35. Gofrit ON, Pizov G, Shapiro A, Duvdevani M, Yutkin V, Landau EH, Zorn KC, Hidas G, Pode D (2014) Mixed high and low grade bladder tumors--are they clinically high or low grade? J Urol 191(6):1693–1696

    PubMed  Google Scholar 

  36. Downes MR, Weening B, van Rhijn BW, Have CL, Treurniet KM, van der Kwast TH (2017) Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway. Histopathology 70(2):281–289

    PubMed  Google Scholar 

  37. Comperat EM, Burger M, Gontero P, Mostafid AH, Palou J, Roupret M et al (2019) Grading of urothelial carcinoma and the new “World Health Organisation classification of tumours of the urinary system and male genital organs 2016”. Eur Urol Focus (3):457–466.

  38. Mikulowski P, Hellsten S (2005) T1 G1 urinary bladder carcinoma: fact or fiction? Scand J Urol Nephrol 39(2):135–137

    PubMed  Google Scholar 

  39. van Rhijn BW, Musquera M, Liu L, Vis AN, Zuiverloon TC, van Leenders GJ et al (2015) Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. Mod Pathol 28(5):695–705

    PubMed  Google Scholar 

  40. Kruger S, Thorns C, Bohle A, Feller AC (2003) Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. Int Urol Nephrol 35(2):169–173

    CAS  PubMed  Google Scholar 

  41. Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW, Hudson MA (2010) Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76(3):593–599

    PubMed  Google Scholar 

  42. Soave A, Schmidt S, Dahlem R, Minner S, Engel O, Kluth LA et al (2015) Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urol Oncol 33(1):21.e1–21.e9

    Google Scholar 

  43. WHO (World Health Organization) (2004) In: Eble J, Sauter G, Epstein J, Sesterhenn I (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organ. IARC Press, Lyon, France

    Google Scholar 

  44. Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol 184(3):888–894

    PubMed  Google Scholar 

  45. Amin MB, Trpkov K, Lopez-Beltran A, Grignon D (2014) Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 38(8):e20–e34

    PubMed  Google Scholar 

  46. Kassouf W, Spiess PE, Brown GA, Munsell MF, Grossman HB, Siefker-Radtke A, Dinney CP, Kamat AM (2007) P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol 52(3):769–774

    PubMed  PubMed Central  Google Scholar 

  47. Ananthanarayanan V, Pan Y, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ, Hansel DE, Jimenez RE, McKenney J, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, Ro JY, Shen SS, Srigley JR, Tsuzuki T, Yao JL, Antic T, Haber M, Taxy JB, Paner GP (2014) Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. Am J Surg Pathol 38(2):167–175

    PubMed  Google Scholar 

  48. Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Karakiewicz PI, Bladder Cancer Research Consortium (2008) Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int 101(4):450–454

    PubMed  Google Scholar 

  49. Neuzillet Y, Lebret T, Molinie V, Yonneau L, Herve JM, Theodore C, Botto H (2012) Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications. BJU Int 110(11):1736–1741

    PubMed  Google Scholar 

  50. Tamas EF, Stephenson AJ, Campbell SC, Montague DK, Trusty DC, Hansel DE (2009) Histopathologic features and clinical outcomes in 71 cases of bladder diverticula. Arch Pathol Lab Med 133(5):791–796

    PubMed  Google Scholar 

  51. Idrees MT, Alexander RE, Kum JB, Cheng L (2013) The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging. Hum Pathol 44(7):1223–1232

    PubMed  Google Scholar 

  52. Walker NF, Gan C, Olsburgh J, Khan MS (2014) Diagnosis and management of intradiverticular bladder tumours. Nat Rev Urol 11(7):383–390

    PubMed  Google Scholar 

  53. Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Roupret M et al (2014) Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 66(5):913–919

    PubMed  Google Scholar 

  54. von Rundstedt FC, Mata DA, Groshen S, Stein JP, Skinner DG, Stadler WM et al (2015) Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial. BJU Int 116(1):44–49

    Google Scholar 

  55. Neuzillet Y, Soulie M, Larre S, Roupret M, Defortescu G, Murez T, Pignot G, Descazeaud A, Patard JJ, Bigot P, Salomon L, Colin P, Rigaud J, Bastide C, Durand X, Valeri A, Kleinclauss F, Bruyere F, Pfister C, Comité de Cancérologie de l’Association Française d'Urologie (CCAFU) (2013) Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study. BJU Int 111(8):1253–1260

    PubMed  Google Scholar 

  56. Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M et al (2007) Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178(6):2308–2312 discussion 13

    PubMed  Google Scholar 

  57. Hadjizacharia P, Stein JP, Cai J, Miranda G (2009) The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer. World J Urol 27(1):33–38

    PubMed  Google Scholar 

  58. Raj GV, Tal R, Vickers A, Bochner BH, Serio A, Donat SM, Herr H, Olgac S, Dalbagni G (2006) Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer 107(9):2167–2172

    PubMed  Google Scholar 

  59. Hoang AN, Agarwal PK, Walton-Diaz A, Wood CG, Metwalli AR, Kassouf W, Brown GA, Black PC, Urbauer DL, Grossman HB, Dinney CP, Kamat AM (2014) Clinical significance of ureteric ‘skip lesions’ at the time of radical cystectomy: the M.D. Anderson experience and literature review. BJU Int 113(5b):E28–E33

    PubMed  Google Scholar 

  60. Schumacher MC, Scholz M, Weise ES, Fleischmann A, Thalmann GN, Studer UE (2006) Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol 176(6 Pt 1):2409–2413 discussion 13

    PubMed  Google Scholar 

  61. Tollefson MK, Blute ML, Farmer SA, Frank I (2010) Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol 183(1):81–86

    PubMed  Google Scholar 

  62. Lee SE, Byun SS, Hong SK, Chang IH, Kim YJ, Gill MC, Song SH, Kim KT (2006) Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy. Urol Int 77(1):13–17

    PubMed  Google Scholar 

  63. Gordetsky J, Bivalacqua T, Schoenberg M, Epstein JI (2014) Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia. Urology 84(3):619–623

    PubMed  Google Scholar 

  64. Amin M, Edge S, Greene F, Byrd D, Brookland R, Washington M et al (2017) AJCC cancer staging manual, 8th edn. Springer, New York

    Google Scholar 

  65. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB (2008) Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 179(5 Suppl):S27–S32

    PubMed  Google Scholar 

  66. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM (2006) Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 37(6):726–734

    PubMed  Google Scholar 

  67. Pagano F, Bassi P, Ferrante GL, Piazza N, Abatangelo G, Pappagallo GL, Garbeglio A (1996) Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 155(1):244–247

    CAS  PubMed  Google Scholar 

  68. Patel P, Reikie BA, Maxwell JP, Yilmaz A, Gotto GT, Trpkov K (2013) Long-term clinical outcome of inverted urothelial papilloma including cases with focal papillary pattern: is continuous surveillance necessary? Urology 82(4):857–860

    PubMed  Google Scholar 

  69. Masson-Lecomte A, Vordos D, Hoznek A, Yiou R, Allory Y, Abbou CC, de la Taille A, Salomon L (2013) External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy. Ann Surg Oncol 20(4):1389–1394

    PubMed  Google Scholar 

  70. Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF (2013) Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol 64(5):837–845

    PubMed  Google Scholar 

  71. Cancer IUa (2016) In: GM BJD, Wittekind C (eds) TNM classification of malignant tumours, 8th edn. Wiley-Blackwell, New York

    Google Scholar 

  72. Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, Kaushik D, Frank I The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol 2013;190(6):2005–10

  73. Picozzi S, Ricci C, Gaeta M, Ratti D, Macchi A, Casellato S, Bozzini G, Carmignani L (2012) Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol 188(6):2046–2054

    PubMed  Google Scholar 

  74. Huguet J, Monllau V, Sabate S, Rodriguez-Faba O, Algaba F, Palou J et al (2008) Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol 53(4):785–792 discussion 92–3

    PubMed  Google Scholar 

  75. Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I (2011) Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol 60(6):1266–1272

    PubMed  Google Scholar 

  76. Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA (2017) Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy. Eur Urol 72(1):54–60

    PubMed  Google Scholar 

  77. Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullen A, Nilsson S et al (2012) Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer. Eur Urol 61(6):1229–1238

    PubMed  Google Scholar 

  78. Fleischmann A, Thalmann GN, Perren A, Seiler R (2014) Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival. Am J Surg Pathol 38(3):325–332

    PubMed  Google Scholar 

  79. Pignot G, Salomon L, Lebacle C, Neuzillet Y, Lunardi P, Rischmann P, Zerbib M, Champy C, Roupret M, Peyronnet B, Verhoest G, Murez T, Quintens H, Larré S, Houédé N, Compérat E, Soulié M, Pfister C (2015) Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study. BJU Int 115(1):87–93

    PubMed  Google Scholar 

  80. Bruins HM, Djaladat H, Ahmadi H, Sherrod A, Cai J, Miranda G, Skinner EC, Daneshmand S (2013) Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. J Urol 190(5):1704–1709

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors (Compérat E, Srigley JR, Brimo F, Delahunt B, Koch M, Lopez-Beltran A, Reuter V, Samaratunga H, Shanks JH, Tsuzuki T, van der Kwast T, Varma M, Webster F Grignon D) have contributed equally to the paper as well with literature research, but also during telephone conferences and discussions. The dataset published online (ICCR-cancer.org) was written by all authors, while the final paper was written by the corresponding author. The paper has been corrected and approved by all authors. Ms. Webster was mainly involved in logistics and editing.

Corresponding author

Correspondence to E. Compérat.

Ethics declarations

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Part of the Topical Collection entitled ‘International Collaboration on Cancer Reporting-Collection’

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Compérat, E., Srigley, J.R., Brimo, F. et al. Dataset for the reporting of carcinoma of the bladder—cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR). Virchows Arch 476, 521–534 (2020). https://doi.org/10.1007/s00428-019-02727-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-019-02727-1

Keywords

Navigation